Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Stellen nieuwe strategie voor:hugin.info/151377/R/1949194/708276.pdf Kan snel gaan:norma.netfonds.no/ppaper.php?paper=PL... En nog een extra voordeel door de goedkope nok.
We zijn langzaam terug aan het stijgen: 0,46 Wijziging (0,11) 31,43% Maar nog lange weg tot 5 Nok van kleine 2 jaar geleden.
Hopelijk morgen een mooi vervolg: 0,56 +0,21 (+59,99%) 49.701.931 Volume bijna 8% van de aandelen. zeker de moeite om de voorstelling eens te bekijken: hugin.info/151377/R/1962305/715693.pdf
Hoe kwam u zo op het idee om in het aandeel Polarcus te beleggen ?
De voorbije dagen meer dan 60% gedaald en nu opnieuw 1,42 10/12/2015 785.111 +24,56% Dec 9, 2015 1.39 Dec 8, 2015 1.61 Dec 7, 2015 1.91 Dec 4, 2015 1.98 Dec 3, 2015 2.09 Dec 2, 2015 2.50 Dec 1, 2015 2.69 Nov 30, 2015 2.75 Nov 27, 2015 2.95 Conclusie IB Het aandeel van Polarcus verdubbelde kortstondig na de bekendmaking van de sterke resultaten. Intussen is onder invloed van de aanhoudende besparingsdrang in de exploratiesector, met de bijbehorende flauwe vooruitzichten voor 2016, de koers opnieuw volledig ingezakt. De schuldpositie blijft een grote zorg, maar toch zien we toenemende redenen tot optimisme. Wel hoog risico. Europese aandelen Advies: koopwaardig Risico: hoog Rating:1C
Aandeel niet voor hartlijders. Plan werd woensdag goedgekeurd en steeg daarop tot 1.60, nu teruggevallen tot 1.09.hugin.info/151377/R/1977011/723715.pdf Jan 28, 2016 1.30 1.36 1.21 1.23 1,436,500 Jan 27, 2016 1.30 1.60 1.29 1.35 957,900 Jan 26, 2016 1.35 1.40 1.30 1.37 329,100 Jan 25, 2016 1.53 1.55 1.40 1.48 94,100 Jan 22, 2016 1.40 1.65 1.35 1.50 516,600 Jan 21, 2016 1.32 1.38 1.31 1.34 149,200 Jan 20, 2016 1.34 1.40 1.30 1.32 219,200 Jan 19, 2016 1.36 1.50 1.36 1.45 136,800 Jan 18, 2016 1.35 1.40 1.33 1.39 78,000 Jan 15, 2016 1.50 1.50 1.33 1.49 168,600 Jan 14, 2016 1.44 1.49 1.25 1.47 484,40 Jan 13, 2016 1.59 1.63 1.45 1.54 167,700 Jan 12, 2016 1.37 1.60 1.21 1.55 793,300 Jan 11, 2016 1.39 1.42 1.29 1.37 177,200 Jan 8, 2016 1.39 1.53 1.33 1.35 555,800 Jan 7, 2016 1.21 1.39 1.11 1.21 843,500 Jan 6, 2016 1.73 2.50 1.38 1.38 2,510,800 Jan 5, 2016 1.86 1.86 1.72 1.77 266,500 Jan 4, 2016 1.65 1.95 1.55 1.75 778,200
Polarcus announces further cost reductions and organizational changes Polarcus ("Polarcus" or the "Company") (OSE: PLCS) further improves its cost position with the announcement of additional headcount reductions and changes to the executive management team. The expanded cost reductions are part of a longer term plan which will continue to improve competitiveness while maintaining exceptional operational performance and sustaining positive operational cash flow. The plan provides the Company with a business model to withstand a prolonged difficult market as well as to take advantage of opportunities in this volatile environment. As part of the comprehensive cost management program implemented at the end of 2014, personnel reductions now total 26%. This additional reduction of 15 employees are all office staff and include executive management positions to fit a redefined Polarcus. Cost savings as a result of these recent personnel changes plus additional other overhead cost reductions will total USD 7 million annually, excluding one-off restructuring costs which will be incurred in Q1 2016. Chief Financial Officer, Tom Henrik Sundby and Senior Vice President Human Resources, Dr. Paul Hanna have made the decision to leave the Company. Additionally, Peter Zickerman, Executive Vice President Strategic Investments and Company founder, has moved from being an employee to a consultant as strategic advisor to the Company. The Executive Vice President Strategic Investments and Senior Vice President Human Resources executive management positions are eliminated as a result of these changes. Effective 1 March 2016, Hans-Peter Burlid will be promoted to the position of Chief Financial Officer. Mr. Burlid currently serves as Vice President Finance & Investor Relations for Polarcus, an executive management position which will be eliminated. He has 12 years of experience in the seismic industry with key roles in finance, accounting and business development and was instrumental in the start-up of Polarcus. Mr. Burlid holds a B.Sc. in Economics and Business Administration from Blekinge Institute of Technology, Sweden. "Firstly, I want to thank all those employees departing the Company for all their hard work and dedication. It is always a difficult decision to see the departure of high-quality employees, but the current market environment requires us to continuously review and adjust our cost structure," stated Rod Starr, Polarcus CEO. "I am also appreciative of the leadership provided by executives Tom Henrik Sundby and Paul Hanna. They were both here in the early days and played important roles in the development of Polarcus, and I wish them the very best in their future endeavors. Continued strategic advice from Peter Zickerman will be an important element as the Company maintains an eye on future growth opportunities." The continued aggressive cost management program combined with leading vessel backlog, operational excellence and innovation and recently announced financial restructuring ensures Polarcus is well positioned to ride out a prolonged market downturn.
Het uitgebreide boekje:norma.netfonds.no/ppaper.php?paper=PL... Weerstand op 1.30 en 1.50.
Had ik toch helemaal niet zien aankomen. 0.97 -0.13 -11.82% (we stonden vandaag al 1.20) Dacht een gouden zaak te doen door recent bij te kopen aan 1.51 en 1.25 en vandaag nog eens aan 1.06. Stond 5 november nog 5.6 euro Ze sloten het 3de kwartaal af met 73 miljoen dollar cash komende van 47.3 miljoen eind 2de kwartaal, de volgende 2 jaren moeten ze maar de interesten meer betalen dus ook al geen probleem. Vreemd. Er komen weliswaar een pak aandelen bij maar toen ze dit aankondigden op 6 januari schoot het aandeel van 1.60 naar 2.50.
Ondertussen waren we helemaal doorgeschoten: 0.87 +0.13 +17.57% Polarcus extends Bareboat agreement with SCF Group Polarcus Limited ("Polarcus" or the "Company") (OSE: PLCS) is pleased to announce the three-year extension of the Bareboat Charter Party Agreement ("BBCP") for M/V Vyacheslav Tikhonov (the "Vessel") between Polarcus Selma Limited ("Polarcus Selma"), Polarcus' wholly owned subsidiary, and SCF Sakhalin Supply Limited ("SCF"). Reference is made to the stock exchange notice published by Polarcus on 11 August 2011 where Polarcus announced a strategic agreement with SCF Group. This extension was carried out pursuant to SCF's option within the terms of the current BBCP (in force since 2011). The vessel charter shall continue for a further period of three years starting from 18 August 2016.
1.16 +0.28 (31.82%) Polarcus Limited ("Polarcus" or the "Company") (OSE: PLCS) is pleased to announce that the Company has received multiple awards which together extend the fleet backlog by six vessel months. The projects will be carried out by multiple Polarcus vessels and commence in Q1 and Q2 2016. Commenting on this latest awards, Duncan Eley, COO Polarcus, said: "Two of the awards are extensions of current projects. Such extensions reflect the excellent performance of our vessels and are beneficial to Polarcus as the fleet utilization can be optimized by increasing backlog without additional transit, which is a very positive factor in the current challenging market."
Toch heel wat lichtpuntjes: 1.2300 NOK + 10.81% Highlights in the fourth quarter 2015: Revenues of USD 72.5 million, down 22% from Q4 2014 Gross cost of sales of USD 54.3 million, down 26% from Q4 2014 Cash from operations of USD 28.6 million, up 263% from Q4 2014 Multi-Client prefunding ratio of 104% Non-cash impairment of USD 242 million relating to carrying values of vessels, equipment and intangibles Completion of financial restructuring post quarter end Backlog USD 210 million "The fourth quarter was one in which we saw the culmination of significant efforts across the organization to successfully execute our 2015 Agenda. We increased market share, announcing nine awards since the end of the last quarter, maintaining an industry-leading backlog. We delivered significant cost reductions, with a 26% decrease in gross cost of sales compared to the same quarter the previous year, with further future cost savings expected following the organizational changes announced post quarter end. Finally, we restructured the balance sheet, which was formally completed in the first quarter 2016, giving us a potential debt reduction of USD 280 million. In addition, we reduce debt service payments by USD 140 million over the next two years alone. Despite a reduction in revenues, we generated cash from operations of USD 28.6 million in the quarter, significantly higher than in the same quarter the previous year. Our investment in Multi-Client remained disciplined, and we recorded a high prefunding level of 104% in the quarter.The Company begins 2016 in a stronger position than ever before ; with a higher market share, a lower cost base and a lower debt burden. Although the market outlook remains challenging during the year ahead, we remain confident that we are well positioned for this prolonged downturn."
Nog een lange weg te gaan maar we kunnen toch al terug onder de mensen komen POLARCUS LTD 1,48 NOK +25,42%
1,80 +0.43 (31.39%) Wat zal dit geven moest de olie terug naar 40 dollar stijgen.
Dalende olieprijs, geen persbericht en toch 1,98 +23,75%
Voor de bodemvissers: 0,64 -40,19% Polarcus is pleased ?? to announce that the Norwegian Financial Supervisory Authority has today approved the prospectus of the Company dated 9 May 2016, for listing of 463,491,579 New Ordinary Shares. The Prospectus also concludes the listing of tranche B of the USD 95 million Senior Unsecured Bond Issue 2013/2018 and tranche B of the NOK 350/500 million Senior Unsecured Bond Issue 2014/2019 (the "B Bonds"). The New Ordinary Shares have until now been registered in the Norwegian Central Securities Depository (VPS) under a separate temporary ISIN, being KYG7153K1408 and registered on the N-OTC under the ticker "PLCSB". The New Ordinary Shares will on 10 May 2016 assume the ordinary ISIN of the Company's shares, KYG7153K1085, and be traded on Oslo Børs under the Company's trading symbol "PLCS". The B Bonds will on 10 May 2016 be traded on Oslo Børs. Tranche B of the USD 95 million Senior Unsecured Bond Issue 2013/2018 will trade under the ticker "PLCS02-B" and trance B of the NOK 350/500 million Senior Unsecured Bond Issue 2014/2019 will trade under the ticker "PLCS03-B".
We hebben het economisch moeilijk vanwege de pandemie.www.basketballlegends.club
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
866,14
-0,90%
EUR/USD
1,0689
-0,08%
FTSE 100
8.049,56
+0,11%
Germany40^
17.839,60
-1,38%
Gold spot
2.320,17
+0,18%
NY-Nasdaq Composite
15.712,75
+0,10%
Stijgers
Dalers